Baby formula manufacturer Abbott Laboratories restarted production Saturday at its Sturgis, Michigan plant that has been closed since February.

Abbott said it will first produce EleCare and other specialty and metabolic formulas which will be available to consumers as early as June 20. The company added that it will restart production of Similac and other formulas as soon as it can.

The company reached an agreement with the Food and Drug Administration after a voluntary recall that has contributed to a baby formula shortage nationwide.

'We understand the urgent need for formula and our top priority is getting high-quality, safe formula into the hands of families across America," Abbott Labs said. "We will ramp production as quickly as we can while meeting all requirements. We're committed to safety and quality and will do everything we can to re-earn the trust parents, caregivers and health care providers have placed in us for 130 years."

The plant in Sturgis, Michigan was shut down in February and several brands of powdered formula were recalled after four infants contracted bacterial infections, leading to hospitalizations and two deaths. Abbott has denied that its plant was responsible for the infections, saying that samples from ill infants did not match the strains of bacteria found in the plant.